37 results on '"Ribaldone D."'
Search Results
2. P1200 Study of correlation between polymorphisms of vitamin D metabolism genes and perianal disease in Crohn's disease
3. P1016 Real-world data on sequential therapy in moderate-to-severe UC: Unveiling second-line strategies after anti-TNF failure
4. P576 Fecal calprotectin could predict clinical and endoscopic response to ustekinumab therapy
5. P497 Malnutrition in inflammatory bowel disease: a correlation between clinical and nutritional parameters
6. P729 Prospective observational study evaluating the effects of GLP1-RA on Inflammatory Bowel Disease (IBD) in patients with Type 2 Diabetes Mellitus (TDM2)
7. P621 Safety and effectiveness of vedolizumab and ustekinumab in inflammatory bowel disease patients after liver transplantation for primary sclerosing cholangitis: results from an ECCO-confer case series
8. P640 Role of vedolizumab trough levels in predicting clinical response in Inflammatory Bowel Disease: a multicentre prospective study
9. DOP79 Promising efficacy of biologicals and small molecules for microscopic colitis: results from a large real-life multicenter cohort
10. P973 Real-world data on the effectiveness on IBD of anti-IL23 drugs prescribed for psoriasis indication
11. P735 JAK inhibitors and S1P receptor modulators for the treatment of antibiotic refractory chronic pouchitis: an ECCO CONFER Multicentre Case Series
12. P908 Real-life effectiveness and safety of tofacitinib and vedolizumab as a second-line therapy in anti-TNFs experienced patients ulcerative colitis: preliminary results of an IGIBD study (VE2TO-UC)
13. P227 The learning curve for using intestinal ultrasonography
14. P169 Circulating eNAMPT predicts anti-TNF response in IBD patients: possible place in therapy of anti-eNAMPT antibody
15. P605 Real life efficacy of tofacitinib in different situation in ulcerative colitis: a retrospective worldwide multicentre collaborative study
16. P217 Volatile organic metabolites to predict clinical response to biological therapy in inflammatory bowel disease
17. P252 Solid organ transplant (with the exception of liver) in patients with inflammatory bowel disease: An ECCO CONFER Multicentre Case Series
18. P674 Ustekinumab is the preferred biological agent in IBD patients with hidradenitis suppurativa failing anti-TNF therapy : results from a real-life multicenter cohort
19. P455 Comparison of two strategies for the management of post-operative recurrence in Crohn’s disease patients with one clinical risk factor: a multicentre IG-IBD study
20. P542 Short term efficacy, safety and thromboembolic risk of tofacitinib in moderate to severe Ulcerative Colitis
21. P260 Autoimmune pancreatitis in patients with Inflammatory Bowel Disease: results from a multicentre ECCO CONFER cases series
22. P268 IBD and Covid-19 in italy: comparisons between first and second pandemic wave
23. P613 Comparative objective effectiveness of vedolizumab and ustekinumab in a real-life cohort of active Crohn’s disease patients failure to TNF inhibitors
24. P150 Increased risk of ibd flare after sars-cov-2 infection. who’s the more guilty: viral infection or therapy withdrawal?
25. P124 Gastroenteropancreatic Neuroendocrine Neoplasms in patients with Inflammatory Bowel Disease: An ECCO CONFER Multicentre Case Series
26. DOP79 Primary hypogammaglobulinemia with IBD-like features: An ECCO CONFER Multicenter Case Series
27. DOP34 Long-term outcome of Acute Severe Ulcerative Colitis responsive to intravenous steroid: A multicenter study of the Italian Group for the study of Inflammatory Bowel Disease (IG-IBD)
28. DOP20 Genetic of vitamin D as predictor of response to adalimumab in Crohn’s Disease
29. P072 The involvement of extracellular Nicotinamide Phosphoribosyltransferase (eNAMPT) and Nicotinate Phosphoribosyltransferase (eNAPRT) in inflammatory bowel disease
30. P164 Celiac Disease among a large cohort of inflammatory bowel disease patients: epidemiology and outcome implications
31. P304 Extranodal primary intestinal lymphoma in inflammatory bowel disease: An ECCO CONFER multi-centre case series
32. P613 Use of adalimumab biosimilar ABP 501 in Crohn’s disease: A real-life experience
33. P783 Long-term colectomy rate in acute severe ulcerative colitis. An observational multi-centre study on behalf of IG-IBD (Italian group for the study of inflammatory bowel disease)
34. P310 Diagnostic delay: assessment, improvement and outcome consequences in inflammatory bowel disease
35. P402 Interstitial and granulomatous lung disease in inflammatory bowel disease patients
36. Prenatal ultrasonic detection of truncus arteriosus with interrupted aortic arch and truncal valve regurgitation
37. Right atrial thrombosis in two premature infants: successful treatment with urokinase and heparin
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.